期刊文献+

扩大切除联合电子线照射治疗隆突性皮肤纤维肉瘤 被引量:6

下载PDF
导出
摘要 目的观察扩大切除联合电子线照射治疗隆突性皮肤纤维肉瘤的疗效及不良反应。方法回顾分析2003年1月至2008年6月荆门市第二人民医院收治的15例隆突性皮肤纤维肉瘤的临床资料,所有患者均先行肿瘤扩大切除术,术后1个月开始接受局部放疗,采用8 MeV电子线行单野垂直照射,200 cGy/次,5次/周,同时加用0.5 cm补偿块,照射至总量为50 Gy后缩野行局部加量照射10 Gy。对治疗中、治疗后不良反应进行观察,并对5年无复发生存率进行统计。结果所有患者电子线照射治疗中、治疗后均未出现明显不良反应。术后随访5年以上,无失访者。15例中仅1例在术后4年时出现局部复发,再次行扩大切除术及术后放疗,无远处转移复发者。5年无复发生存率为93.3%,复发率为6.7%。结论扩大切除联合电子线照射治疗隆突性皮肤纤维肉瘤,疗效确切,不良反应轻,值得临床推广应用。
出处 《中国肿瘤外科杂志》 CAS 2014年第4期257-258,共2页 Chinese Journal of Surgical Oncology
  • 相关文献

参考文献8

二级参考文献75

  • 1徐建明,宋三泰.表皮生长因子受体酪氨酸激酶靶向药物与化疗联合应用的合理设计[J].中华肿瘤杂志,2004,26(6):321-323. 被引量:20
  • 2杨连君,司晓辉.隆突性皮肤纤维肉瘤的病理特点及其鉴别诊断[J].临床误诊误治,2005,18(12):904-906. 被引量:14
  • 3周海清 王兵.扩大切除治疗隆突性皮肤纤维肉瘤九例[J].中华皮肤科杂志,2000,33(2):95-95.
  • 4Wacker J, Khan-Durani B, Hartschuh W. Modified mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol, 2004,11 : 438- 444.
  • 5DuBay D, Cimmino V, Lowe L, et al. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer, 2004, 100: 1008- 1016.
  • 6Gloster Jr HM. Dermatofibrosareoma protuberans. J Am Acad Dermatol, 1996,35 : 355-374.
  • 7熊敏.纤维组织肿瘤及瘤样病变//赖日权.软组织肿瘤病理学.1版.北京:人民军医出版社,1998:57-59.
  • 8林建韶.良性纤维组织细胞肿瘤和瘤样病变//范螂娣,王德延.肿瘤病理诊断学.2版.天津:天津科学技术出版社,1999:205-206.
  • 9Lindner NJ, Scarborough MT,Powell GJ, et al. Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol , 1999,25:392-397.
  • 10Gloster Jr HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol, 1996,35:82-87.

共引文献43

同被引文献66

  • 1王配合,杨建民,孙志刚,刘建春,李晓东,王鹏,安亮恩.误诊为瘢痕的皮肤隆突性纤维肉瘤[J].临床误诊误治,2005,18(6):453-454. 被引量:5
  • 2Goldblum J R, Tuthill R J. CD34 and factor-X 111 a immu- noreactivity in dermatofibrosarcoma protuberans and der- matofibroma[ J ]. Am J Dermatopathol, 1997, 19 (2) : 147-153.
  • 3Kabatas S, Cansever T, Yilmaz C, et al. Giant cranio- cervical junction schwannoma involving the hypoglossal nerve : case report [ J ]. Turk Neurosurg, 2010,20 ( 1 ) : 73 -76.
  • 4FIELDS R C, HAMEED M, QIN L X, et al. Dermat- ofibrosarcoma protuberans(DFSP): predictors of re- currence and the use of systemic therapy[J]. Ann Surg Oncol,2011,18 : 328-- 336.
  • 5RESNIK K S, DILEONARDO M, HUNTER C J. Pe- dunculated presentation of derrnatofibrosarcorna protuber- ans[J]. J Am Acad Dermatol, 2003,49 :1139-- 1141.
  • 6KAHN H J,FEKETE E,FROM L. Tenascin differ- entiates dermatofibroma from dermatofibrosarcoma protuberans comparison with CD34 and factor X 11 a [J]. Hum Pathol, 2001,32 : 50-- 56.
  • 7LEMM D, MUGGE L, MENTZEL T, et al. Current treatment option in dermatofibrosarcoma protuberans [J]. J Cancer Res Clin Oncol, 2009,135: 653-- 665.
  • 8Llombart B, Serra-Guill6n C, Monteagudo C, et al. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management [J].Semin Diagn Pathol, 2013, 30(1): 13-28.
  • 9Tsai Y J, Lin PY, Chew KY, et al. Dermatofibrosarcoma protuberans in children and adolescents: clinical presentation, histology, treatment, and review of the literature [J]. J Plast Reconstr Aesthet Surg, 2014, 67(9): 1222-1229.
  • 10Serra-Guill6n C, Llombart B, Sanmartfn O. Dermatofibrosarcoma protuberans[J]. Actas Dermosifiliogr, 2012, 103(9): 762-777.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部